Tumor-Associated Immune Cells Hinder Frontline Chemotherapy Drug in Pancreatic Cancer

Costas Lyssiotis, PhD, and researchers in his lab show how tumor-associated macrophages release compounds that block gemcitabine in the most common type of pancreatic cancer.